(Total Views: 122)
Posted On: 12/10/2020 9:51:38 AM
Post# of 106586
PURA and ALKM Announce New CBD Infused Creations - Pets, Confections and Sexual Wellness
PR Newswire
DALLAS, Dec. 10, 2020
DALLAS, Dec. 10, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) and Alkame Holdings Inc. (USOTC: ALKM) today announced the two companies plan to produce and test market a CBD infused liquid sugar, a CBD infused pet food supplement and a CBD sexual wellness flavored lubricant.
ALKM currently bottles PURA's EVERx CBD Sports Water. As part of a growing partnership, PURA has recently acquired a five percent stake in ALKM. In conjunction with that growing partnership, ALKM and PURA plan to pilot the production of multiple new CBD infused consumer products.
PURA owns a license to a U.S. Patented cannabis extraction process backed by extensive university medical research. The license, issued by NCM Biotech, is exclusive for beverages, edibles and cosmetics among other uses. NCM Biotech is focused on medical research and Puration has access to that research.
PURA and ALKM plan to release details on each of the new products announced today in coming separate releases. The pilot production of the new products is scheduled to start in 2021.
PR Newswire
DALLAS, Dec. 10, 2020
DALLAS, Dec. 10, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) and Alkame Holdings Inc. (USOTC: ALKM) today announced the two companies plan to produce and test market a CBD infused liquid sugar, a CBD infused pet food supplement and a CBD sexual wellness flavored lubricant.
ALKM currently bottles PURA's EVERx CBD Sports Water. As part of a growing partnership, PURA has recently acquired a five percent stake in ALKM. In conjunction with that growing partnership, ALKM and PURA plan to pilot the production of multiple new CBD infused consumer products.
PURA owns a license to a U.S. Patented cannabis extraction process backed by extensive university medical research. The license, issued by NCM Biotech, is exclusive for beverages, edibles and cosmetics among other uses. NCM Biotech is focused on medical research and Puration has access to that research.
PURA and ALKM plan to release details on each of the new products announced today in coming separate releases. The pilot production of the new products is scheduled to start in 2021.
(0)
(0)
